Literature DB >> 3624498

Influence of 5-hydroxytryptamine on crypt cell production rate of human duodenal mucosa cultured in vitro.

E E Wheeler, D N Challacombe.   

Abstract

The effect of 5-hydroxytryptamine (5-HT) on the crypt cell production rate in normal human duodenal mucosa cultured in vitro was studied using a stathmokinetic technique with crypt microdissection. The addition of 5-HT (2 mg/ml) to the culture medium significantly increased the crypt cell production rate (p less than 0.001), suggesting that this amine may have a trophic effect on crypt cells in vitro. Increased synthesis and release of 5-HT from enterochromaffin cells in patients with coeliac disease may increase the crypt cell production rate and lead to a flattened small intestinal mucosa.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3624498      PMCID: PMC1141085          DOI: 10.1136/jcp.40.7.710

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  15 in total

1.  Increased excretion of 5-hydroxyindoleacetic acid in urine of children with untreated coeliac disease.

Authors:  D N Challacombe; G A Brown; S C Black; M H Storrie
Journal:  Arch Dis Child       Date:  1972-06       Impact factor: 3.791

2.  Malignant carcinoid tumour complicating coeliac disease.

Authors:  C Hallert; K Norrby
Journal:  Acta Med Scand       Date:  1983

3.  Urinary 5-hydroxyindoleacetic acid in 8-hour collections as an aid in diagnosis of coeliac disease.

Authors:  D N Challacombe; M Goodall; H Gaze; G A Brown
Journal:  Arch Dis Child       Date:  1975-10       Impact factor: 3.791

4.  Cell kinetics in flat (avillous) mucosa of the human small intestine.

Authors:  N Wright; A Watson; A Morley; D Appleton; J Marks
Journal:  Gut       Date:  1973-09       Impact factor: 23.059

5.  Increased tissue concentrations of 5-hydroxytryptamine in the duodenal mucosa of patients with coeliac disease.

Authors:  D N Challacombe; P D Dawkins; P Baker
Journal:  Gut       Date:  1977-11       Impact factor: 23.059

6.  Measurement of the 5-hydroxyindoleacetic acid/creatinine ration in the urine of patients with coeliac disease.

Authors:  D N Challacombe; P G Hammond; P Crewe; P D Dawkins
Journal:  Hepatogastroenterology       Date:  1981-06

7.  Increased levels of plasma 5-hydroxytryptamine in patients with coeliac disease.

Authors:  K Sjölund; A Nobin
Journal:  Scand J Gastroenterol       Date:  1985-04       Impact factor: 2.423

8.  Raised 5-hydroxytryptamine concentrations in enterochromaffin cells in adult coeliac disease.

Authors:  L Enerbäck; C Hallert; K Norrby
Journal:  J Clin Pathol       Date:  1983-05       Impact factor: 3.411

9.  The cell cycle time in the flat (avillous) mucosa of the human small intestine.

Authors:  N Wright; A Watson; A Morley; D Appleton; J Marks; A Douglas
Journal:  Gut       Date:  1973-08       Impact factor: 23.059

10.  Enteropathy of coeliac disease in adults: increased number of enterochromaffin cells the duodenal mucosa.

Authors:  K Sjölund; J Alumets; N O Berg; R Håkanson; F Sundler
Journal:  Gut       Date:  1982-01       Impact factor: 23.059

View more
  1 in total

1.  Trophic action of epidermal growth factor on human duodenal mucosa cultured in vitro.

Authors:  D N Challacombe; E E Wheeler
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.